Canada
Search    
Include All CSL Behring Country Sites

News Room

The most recent items of news in the Canadian Region are:

02/22/2017
Rare Disease Day February 28th 2017
Ottawa – CSL Behring Canada staff raise and join their hands in support of patients with Rare Disease. Raise and Join your hands for Rare Disease Day February 28th 2017. More.

12/14/2016
Health Canada Approves CSL Behring’s AFSTYLA for the Treatment of Hemophilia A
Health Canada has approved AFSTYLA [Antihemophilic Factor VIII (Recombinant), SingleChain], CSL Behring’s novel long-lasting recombinant factor VIII single-chain therapy for adults and children with hemophilia A. More.